| 0 | ℹ |
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.
(nejm.org)
|
New England Journal of Medicine 2026-05-29 | #clinical trial #mutation #nsclc #targeted therapy #egfr |